Embryonic stem cell markers expression in cancers

Biochemical and Biophysical Research Communications

Volumn 383, Issue 2, 2009, Pages 157-162

  Schoenhals, Matthieu ^b   Kassambara, Alboukadel ^b   Vos, John De ^a,b,c   Hose, Dirk ^d   Moreaux, Jérôme ^a,b   Klein, Bernard ^a,b,c  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIV MONTPELLIER   (France)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

c Myc; Cancer; Klf4; Microarray; Oct4; Pluripotency; Sox2; Stem cell

Indexed keywords

KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2; TUMOR MARKER;

ARTICLE; BRAIN CANCER; BREAST CARCINOMA; BURKITT LYMPHOMA; CANCER GRADING; CELL RENEWAL; DATA BASE; EMBRYONIC STEM CELL; LARGE CELL LYMPHOMA; LUNG NON SMALL CELL CANCER; MELANOMA; MICROARRAY ANALYSIS; MULTIPLE MYELOMA; NEOPLASM; OVARY CARCINOMA; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SOLID TUMOR; TUMOR GROWTH;

DATABASES, GENETIC; EMBRYONIC STEM CELLS; HUMANS; NEOPLASM STAGING; NEOPLASMS; PLURIPOTENT STEM CELLS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 65049086409     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.02.156     Document Type: Article

References (46)

1. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
2. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
3. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H., Jones D.L., Visvader J., Weissman I.L., and Wahl G.M. Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 66 (2006) 9339-9344
4. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
5. Visvader J.E., and Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8 (2008) 755-768
6. Sotomayor P., Godoy A., Smith G.J., and Huss W.J. Oct4A is expressed by a subpopulation of prostate neuroendocrine cells. Prostate 69 (2009) 401-410
7. Hochedlinger K., Yamada Y., Beard C., and Jaenisch R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121 (2005) 465-477
8. Bani-Yaghoub M., Tremblay R.G., Lei J.X., Zhang D., Zurakowski B., Sandhu J.K., Smith B., Ribecco-Lutkiewicz M., Kennedy J., Walker P.R., and Sikorska M. Role of Sox2 in the development of the mouse neocortex. Dev. Biol. 295 (2006) 52-66
9. Cavallaro M., Mariani J., Lancini C., Latorre E., Caccia R., Gullo F., Valotta M., DeBiasi S., Spinardi L., Ronchi A., Wanke E., Brunelli S., Favaro R., Ottolenghi S., and Nicolis S.K. Impaired generation of mature neurons by neural stem cells from hypomorphic Sox2 mutants. Development 135 (2008) 541-557
10. R.M. Gangemi, F. Griffero, D. Marubbi, M. Perera, M.C. Capra, P. Malatesta, G.L. Ravetti, G.L. Zona, A. Daga, G. Corte, SOX2 silencing in glioblastoma tumor initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells (2008) [Epub ahead of print].
11. Gu G., Yuan J., Wills M., and Kasper S. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res. 67 (2007) 4807-4815
12. Rodriguez-Pinilla S.M., Sarrio D., Moreno-Bueno G., Rodriguez-Gil Y., Martinez M.A., Hernandez L., Hardisson D., Reis-Filho J.S., and Palacios J. Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer. Mod. Pathol. 20 (2007) 474-481
13. Spisek R., Kukreja A., Chen L.C., Matthews P., Mazumder A., Vesole D., Jagannath S., Zebroski H.A., Simpson A.J., Ritter G., Durie B., Crowley J., Shaughnessy Jr. J.D., Scanlan M.J., Gure A.O., Barlogie B., and Dhodapkar M.V. Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy. J. Exp. Med. 204 (2007) 831-840
14. Adhikary S., and Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol. 6 (2005) 635-645
15. Cole M.D., and Nikiforov M.A. Transcriptional activation by the Myc oncoprotein. Curr. Top. Microbiol. Immunol. 302 (2006) 33-50
16. Kim J.B., Zaehres H., Wu G., Gentile L., Ko K., Sebastiano V., Arauzo-Bravo M.J., Ruau D., Han D.W., Zenke M., and Scholer H.R. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454 (2008) 646-650
17. Hanna J., Markoulaki S., Schorderet P., Carey B.W., Beard C., Wernig M., Creyghton M.P., Steine E.J., Cassady J.P., Foreman R., Lengner C.J., Dausman J.A., and Jaenisch R. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133 (2008) 250-264
18. Okita K., Ichisaka T., and Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 448 (2007) 313-317
19. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., Bernstein B.E., and Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448 (2007) 318-324
20. Eilers M., and Eisenman R.N. Myc's broad reach. Genes Dev. 22 (2008) 2755-2766
21. Strasser A., Elefanty A.G., Harris A.W., and Cory S. Progenitor tumours from Emu-bcl-2-myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival. EMBO J. 15 (1996) 3823-3834
22. Shachaf C.M., Kopelman A.M., Arvanitis C., Karlsson A., Beer S., Mandl S., Bachmann M.H., Borowsky A.D., Ruebner B., Cardiff R.D., Yang Q., Bishop J.M., Contag C.H., and Felsher D.W. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431 (2004) 1112-1117
23. Evans P.M., and Liu C. Roles of Krupel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim. Biophys. Sin. (Shanghai) 40 (2008) 554-564
24. McConnell B.B., Ghaleb A.M., Nandan M.O., and Yang V.W. The diverse functions of Kruppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays 29 (2007) 549-557
25. Wei D., Kanai M., Huang S., and Xie K. Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis 27 (2006) 23-31
26. Rowland B.D., and Peeper D.S. KLF4, p21 and context-dependent opposing forces in cancer. Nat. Rev. Cancer 6 (2006) 11-23
27. Foster K.W., Ren S., Louro I.D., Lobo-Ruppert S.M., McKie-Bell P., Grizzle W., Hayes M.R., Broker T.R., Chow L.T., and Ruppert J.M. Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. Cell Growth Differ. 10 (1999) 423-434
28. Foster K.W., Frost A.R., McKie-Bell P., Lin C.Y., Engler J.A., Grizzle W.E., and Ruppert J.M. Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res. 60 (2000) 6488-6495
29. Pandya A.Y., Talley L.I., Frost A.R., Fitzgerald T.J., Trivedi V., Chakravarthy M., Chhieng D.C., Grizzle W.E., Engler J.A., Krontiras H., Bland K.I., LoBuglio A.F., Lobo-Ruppert S.M., and Ruppert J.M. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin. Cancer Res. 10 (2004) 2709-2719
30. Foster K.W., Liu Z., Nail C.D., Li X., Fitzgerald T.J., Bailey S.K., Frost A.R., Louro I.D., Townes T.M., Paterson A.J., Kudlow J.E., Lobo-Ruppert S.M., and Ruppert J.M. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene 24 (2005) 1491-1500
31. Huang C.C., Liu Z., Li X., Bailey S.K., Nail C.D., Foster K.W., Frost A.R., Ruppert J.M., and Lobo-Ruppert S.M. KLF4 and PCNA identify stages of tumor initiation in a conditional model of cutaneous squamous epithelial neoplasia. Cancer Biol. Ther. 4 (2005) 1401-1408
32. Ben-Porath I., Thomson M.W., Carey V.J., Ge R., Bell G.W., Regev A., and Weinberg R.A. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 40 (2008) 499-507
33. Quintana E., Shackleton M., Sabel M.S., Fullen D.R., Johnson T.M., and Morrison S.J. Efficient tumour formation by single human melanoma cells. Nature 456 (2008) 593-598
34. Rhodes D.R., Yu J., Shanker K., Deshpande N., Varambally R., Ghosh D., Barrette T., Pandey A., and Chinnaiyan A.M. Oncomine: a cancer microarray database and integrated data-mining platform. Neoplasia 6 (2004) 1-6
35. Assou S., Le Carrour T., Tondeur S., Strom S., Gabelle A., Marty S., Nadal L., Pantesco V., Reme T., Hugnot J.P., Gasca S., Hovatta O., Hamamah S., Klein B., and De Vos J. A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Stem Cells 25 (2007) 961-973
36. Reme T., Hose D., De Vos J., Vassal A., Poulain P.O., Pantesco V., Goldschmidt H., and Klein B. A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments. BMC Bioinformatics 9 (2008) 16
37. Bild A.H., Yao G., Chang J.T., Wang Q., Potti A., Chasse D., Joshi M.B., Harpole D., Lancaster J.M., Berchuck A., Olson Jr. J.A., Marks J.R., Dressman H.K., West M., and Nevins J.R. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439 (2006) 353-357
38. Xu L., Shen S.S., Hoshida Y., Subramanian A., Ross K., Brunet J.P., Wagner S.N., Ramaswamy S., Mesirov J.P., and Hynes R.O. Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases. Mol. Cancer Res. 6 (2008) 760-769
39. Tomida S., Koshikawa K., Yatabe Y., Harano T., Ogura N., Mitsudomi T., Some M., Yanagisawa K., Takahashi T., and Osada H. Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients. Oncogene 23 (2004) 5360-5370
40. Shai R., Shi T., Kremen T.J., Horvath S., Liau L.M., Cloughesy T.F., Mischel P.S., and Nelson S.F. Gene expression profiling identifies molecular subtypes of gliomas. Oncogene 22 (2003) 4918-4923
41. Desmedt C., Piette F., Loi S., Wang Y., Lallemand F., Haibe-Kains B., Viale G., Delorenzi M., Zhang Y., d'Assignies M.S., Bergh J., Lidereau R., Ellis P., Harris A.L., Klijn J.G., Foekens J.A., Cardoso F., Piccart M.J., Buyse M., and Sotiriou C. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin. Cancer Res. 13 (2007) 3207-3214
42. Alizadeh A.A., Eisen M.B., Davis R.E., Ma C., Lossos I.S., Rosenwald A., Boldrick J.C., Sabet H., Tran T., Yu X., Powell J.I., Yang L., Marti G.E., Moore T., Hudson Jr. J., Lu L., Lewis D.B., Tibshirani R., Sherlock G., Chan W.C., Greiner T.C., Weisenburger D.D., Armitage J.O., Warnke R., Levy R., Wilson W., Grever M.R., Byrd J.C., Botstein D., Brown P.O., and Staudt L.M. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 (2000) 503-511
43. Shipp M.A., Ross K.N., Tamayo P., Weng A.P., Kutok J.L., Aguiar R.C., Gaasenbeek M., Angelo M., Reich M., Pinkus G.S., Ray T.S., Koval M.A., Last K.W., Norton A., Lister T.A., Mesirov J., Neuberg D.S., Lander E.S., Aster J.C., and Golub T.R. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat. Med. 8 (2002) 68-74
44. Dave S.S., Fu K., Wright G.W., Lam L.T., Kluin P., Boerma E.J., Greiner T.C., Weisenburger D.D., Rosenwald A., Ott G., Muller-Hermelink H.K., Gascoyne R.D., Delabie J., Rimsza L.M., Braziel R.M., Grogan T.M., Campo E., Jaffe E.S., Dave B.J., Sanger W., Bast M., Vose J.M., Armitage J.O., Connors J.M., Smeland E.B., Kvaloy S., Holte H., Fisher R.I., Miller T.P., Montserrat E., Wilson W.H., Bahl M., Zhao H., Yang L., Powell J., Simon R., Chan W.C., and Staudt L.M. Molecular diagnosis of Burkitt's lymphoma. N. Engl. J. Med. 354 (2006) 2431-2442
45. Carrasco D.R., Tonon G., Huang Y., Zhang Y., Sinha R., Feng B., Stewart J.P., Zhan F., Khatry D., Protopopova M., Protopopov A., Sukhdeo K., Hanamura I., Stephens O., Barlogie B., Anderson K.C., Chin L., Shaughnessy Jr. J.D., Brennan C., and Depinho R.A. High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell 9 (2006) 313-325
46. Wong D.J., Liu H., Ridky T.W., Cassarino D., Segal E., and Chang H.Y. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2 (2008) 333-344